1. Home
  2. SKIN vs EARN Comparison

SKIN vs EARN Comparison

Compare SKIN & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Beauty Health Company

SKIN

The Beauty Health Company

HOLD

Current Price

$1.47

Market Cap

202.7M

ML Signal

HOLD

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$5.32

Market Cap

189.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKIN
EARN
Founded
1997
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Real Estate Investment Trusts
Sector
Consumer Discretionary
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
202.7M
189.7M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SKIN
EARN
Price
$1.47
$5.32
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$2.42
$5.88
AVG Volume (30 Days)
684.3K
309.1K
Earning Date
11-06-2025
02-20-2026
Dividend Yield
N/A
18.01%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$301,917,000.00
$35,893,000.00
Revenue This Year
N/A
$8.43
Revenue Next Year
$4.41
$17.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.30
52 Week Low
$0.78
$4.33
52 Week High
$2.69
$6.86

Technical Indicators

Market Signals
Indicator
SKIN
EARN
Relative Strength Index (RSI) 51.06 55.68
Support Level $1.43 $5.15
Resistance Level $1.57 $5.35
Average True Range (ATR) 0.09 0.10
MACD 0.00 0.01
Stochastic Oscillator 54.90 81.67

Price Performance

Historical Comparison
SKIN
EARN

About SKIN The Beauty Health Company

The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

Share on Social Networks: